Navigation Links
Michael A. Marletta Takes Office as New President of Scripps Research Institute
Date:1/2/2012

LA JOLLA, Calif., Jan. 2, 2012 /PRNewswire/ -- Renowned biochemist Michael A. Marletta, PhD, assumed the post of president and CEO of The Scripps Research Institute January 1, succeeding Richard A. Lerner, MD, who led the institution for more than two decades.

(Photo:  http://photos.prnewswire.com/prnh/20120102/DC28698 )

"I'm excited by the opportunity to advance the institute's mission, creating knowledge in the biosciences and applying that knowledge to understanding and curing human disease," said Marletta. "I also look forward to working with all the dynamic, committed people who make the institute's work possible."

Marletta moved to Scripps Research from the University of California, Berkeley, where he served as chair of the Department of Chemistry, co-director of the Chemical Biology Graduate Program, Aldo DeBenedictis Distinguished Professor of Chemistry, and Professor of Biochemistry in the Department of Molecular and Cell Biology. He joined the Scripps Research faculty July 1, 2011, following his selection by the Board of Trustees as the institute's next head.

A former recipient of the prestigious MacArthur Fellowship as well as many other awards and honors, Marletta has focused his laboratory research on the intersection of chemistry and biology. He is an acknowledged pioneer in discovering the role of nitric oxide, a critical player in communication between cells.

Marletta is the third head of the institute in the 50 years since it began its focus on basic biomedical research. Its first director was Frank Dixon, MD, who arrived with his colleagues at the Scripps Clinic and Research Foundation (a forerunner of The Scripps Research Institute) in 1961 and was appointed head of research operations in 1970. Lerner, who had led the institute since 1987, will remain a member of the Scripps Research faculty.

For more information on Marletta, see his Scripps Research faculty web page at http://www.scripps.edu/research/faculty/marletta

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neuroscience, and vaccine development, as well as for its insights into autoimmune, cardiovascular, and infectious disease. Headquartered in La Jolla, California, the institute also includes a campus in Jupiter, Florida, where scientists focus on drug discovery and technology development in addition to basic biomedical science. Scripps Research currently employs about 3,000 scientists, staff, postdoctoral fellows, and graduate students on its two campuses. The institute's graduate program, which awards PhD degrees in biology and chemistry, is ranked among the top ten such programs in the nation. For more information, see www.scripps.edu


'/>"/>
SOURCE Scripps Research Institute
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
2. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
3. NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer
4. Oramed Pharmaceuticals Appoints Dr. Michael Berelowitz as Chairman of Scientific Advisory Board
5. Netsmart Technologies Names Michael Valentine as Chief Executive Officer
6. BioNeutral Appoints Michael D. Francis, J.D. as Director to the Board
7. Michael J. Fox Foundation Awards Grant to Zymes LLC
8. Dr. Michael Hanley Joins Celtaxsys as CEO
9. NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of a New Dermal Patch for Parkinsons Disease
10. Vaccinogen Names Veteran Biotech Executive Michael Kranda President & CEO
11. Michael J. Fox Foundation Launches Parkinsons Progression Markers Initiative (PPMI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 Aviva Systems Biology Corporation (ASB) ... of GenWay Biotech Incorporated, a protein solutions and ... offering for both the research and diagnostic markets. ... enhance capabilities for both entities. GenWay,s 18 years of ... nicely complement ASB,s objective to become a leading ...
(Date:2/22/2017)... Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on ... companion animals, will host a live conference call on Tuesday, ... results from the fourth quarter and full year ended December ... access the audio webcast or use the conference ... ...
(Date:2/22/2017)... 22, 2017  PrimeVax Immuno-Oncology, Inc. announced today its ... the Annual Biocom Global Life Science Partnering Conference.  The ... AM, at the Torrey Pines Lodge, in San Diego.  ... at Biocom who have chosen our company, amongst numerous ... companies, investors, and clinical researchers," said Mr. Chen. "In ...
(Date:2/22/2017)... ... February 22, 2017 , ... ProMIS Neurosciences ... treatments for neurodegenerative diseases, today announced it has issued a scientific white paper ... one of a series of commentaries from ProMIS’s scientific team offering insight into ...
Breaking Biology Technology:
(Date:2/10/2017)... , Feb 10, 2017 ... new report "Personalized Medicine - Scientific and Commercial Aspects" ... ... personalized medicine. Diagnosis is integrated with therapy for selection of ... on early detection and prevention of disease in modern medicine. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
Breaking Biology News(10 mins):